MD Pediatrix Medical Group, Inc.
USHealthcareAs of 2026-07-10 13:15
Why MD matters now
Pediatrix Medical Group, Inc. (MD) is a US stock in Healthcare. The latest InvestLog snapshot shows $26.30 with -2.30% on the session and $2.16B in market capitalization; recent performance reads 1-month +2.61% and YTD +10.38%.
The latest financial table shown here is Q1 2026, with revenue of $476.2M, net income of $29.6M, and EPS of $0.36. Investors can compare that operating picture with valuation signals such as P/E 10.92 and FCF yield 12.3%.
The latest indexable market news headline is "Pediatrix Medical Group (MD) is a Top-Ranked Growth Stock: Should You Buy?" from Zacks Investment Research.
Additional event context on this page matters because analyst consensus is Hold with a median target of $24.00; recent insider activity includes Moore Mary Ann E filing G-Gift. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
10.92
PEG
0.04
P/B
2.23
P/S
1.00
EV/EBITDA
8.47
DCF Value
$25.94
FCF Yield
12.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
25.8%
Operating Margin
11.9%
Net Margin
9.0%
ROE
20.1%
ROA
8.4%
ROIC
9.6%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $476.2M | $29.6M | $0.36 |
| Q4 2025 | $493.8M | $33.7M | $0.40 |
| FY 2025 | $1.91B | $165.4M | $1.94 |
| Q3 2025 | $492.9M | $71.7M | $0.84 |
Analyst Ratings
Consensus
Hold
Target (Consensus)
$23.20
Target (Median)
$24.00
Target Range
$19.00 - $27.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Care Facilities
Country
US
Exchange
—
Beta
0.70
Pediatrix Medical Group, Inc. delivers specialized medical services for newborns, expectant mothers, and pediatric patients across the United States and Puerto Rico. The company offers crucial neonatal care to critically ill or prematurely born infants within hospital units, staffed by expert neonatal subspecialists and advanced practice clinicians. For pregnant individuals and their developing babies, Pediatrix provides comprehensive maternal-fetal medicine services in both clinical and inpatient settings, involving specialists such as maternal-fetal medicine physicians, obstetricians, and genetic counselors. Furthermore, the group delivers pediatric cardiology services, addressing both congenital and acquired heart conditions in patients ranging from the fetal stage through adulthood, under the care of dedicated pediatric cardiologists. Beyond these core areas, Pediatrix extends its expertise to various other pediatric subspecialties, including those requiring intensivists, surgeons, and ophthalmologists, and supplies vital support to hospital departments like emergency rooms and labor and delivery units. Established in 1979 in Sunrise, Florida, and formerly known as MEDNAX, Inc. until its renaming in July 2022, the company managed a network of approximately 2,700 physicians as of February 2022.